Inventor · disambiguated record
Nigel J. Liverton
Also filed as: LIVERTON NIGEL · LIVERTON NIGEL J · LIVERTON NIGEL JOHN
83 granted patents·13 pending applications·1,499 citations·filing 1993–2022
99Inventor score
Top patents by PatentIndex Score
96 records- 0197US7470664B2HCV NS3 protease inhibitorsMERCK & CO INC·Filed 2006·Granted Dec 30, 2008·81 cites·40 claims
- 0297US5717100ASubstituted imidazoles having anti-cancer and cytokine inhibitory activityMERCK & CO INC·Filed 1996·Granted Feb 10, 1998·116 cites·33 claims
- 0396US7973040B2Macrocyclic quinoxaline compounds as HCV NS3 protease inhibitorsMERCK SHARP & DOHME·Filed 2009·Granted Jul 5, 2011·40 cites·12 claims
- 0495US5633251AN-2,3-dihydro-1-(2-propyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepinesMERCK & CO INC·Filed 1995·Granted May 27, 1997·90 cites·11 claims
- 0594US8080654B2Macrocyclic quinoxaline compounds as HCV NS3 protease inhibitorsHARPER STEVEN·Filed 2011·Granted Dec 20, 2011·36 cites·8 claims
- 0694US5837719A2,5-substituted aryl pyrroles, compositions containing such compounds and methods of useMERCK & CO INC·Filed 1996·Granted Nov 17, 1998·77 cites·25 claims
- 0793US5859041ASubstituted imidazoles having cytokine inhibitory activityMERCK & CO INC·Filed 1997·Granted Jan 12, 1999·135 cites·24 claims
- 0893US5595990AAntiarrhythmic benzodiazepinesMERCK & CO INC·Filed 1995·Granted Jan 21, 1997·61 cites·10 claims
- 0993US5389631AFibrinogen receptor antagonistsMERCK & CO INC·Filed 1993·Granted Feb 14, 1995·58 cites·11 claims
- 1092US10011595B2Ethyldiamine orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2015·Granted Jul 3, 2018·7 cites·10 claims
- 1192US5792778A2-substituted aryl pyrroles, compositions containing such compounds and methods of useMERCK & CO INC·Filed 1996·Granted Aug 11, 1998·63 cites·13 claims
- 1291US8216999B2HCV NS3 protease inhibitorsHOLLOWAY M KATHARINE·Filed 2008·Granted Jul 10, 2012·26 cites·18 claims
- 1391US7879797B2HCV NS3 protease inhibitorsMERCK SHARP & DOHME·Filed 2006·Granted Feb 1, 2011·15 cites·16 claims
- 1490US6870055B2Isoquinolinone potassium channels inhibitorsMERCK & CO INC·Filed 2001·Granted Mar 22, 2005·28 cites·10 claims
- 1590US6316474B12-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonistsMERCK & CO INC·Filed 2000·Granted Nov 13, 2001·43 cites·13 claims
- 1689US8278322B2HCV NS3 protease inhibitorsHOLLOWAY M KATHARINE·Filed 2006·Granted Oct 2, 2012·10 cites·40 claims
- 1788US9265773B2Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseasesMCCOMAS CASEY C·Filed 2012·Granted Feb 23, 2016·8 cites·15 claims
- 1887US8461107B2HCV NS3 protease inhibitorsLIVERTON NIGEL J·Filed 2009·Granted Jun 11, 2013·12 cites·26 claims
- 1987US7592360B23-fluoro-piperidines as NMDA/NR2B antagonistsMERCK & CO INC·Filed 2004·Granted Sep 22, 2009·18 cites·32 claims
- 2086US8377874B2HCV NS3 protease inhibitorsMERCK SHARP & DOHME·Filed 2007·Granted Feb 19, 2013·9 cites·13 claims
- 2186US8138164B2HCV NS3 protease inhibitorsLIVERTON NIGEL J·Filed 2007·Granted Mar 20, 2012·11 cites·21 claims
- 2285US8828930B2Hepatitis C virus NS3 protease inhibitorsLIVERTON NIGEL J·Filed 2010·Granted Sep 9, 2014·8 cites·6 claims
- 2385US8309540B2HCV NS3 protease inhibitorsLIVERTON NIGEL J·Filed 2007·Granted Nov 13, 2012·9 cites·24 claims
- 2485US6376530B1Cyclic amidines useful as NMDA NR2B antagonistsMERCK & CO INC·Filed 2000·Granted Apr 23, 2002·22 cites·17 claims
- 2584US8377873B2HCV NS3 protease inhibitorsMERCK SHARP & DOHME·Filed 2007·Granted Feb 19, 2013·9 cites·16 claims
- 2684US6403596B1Substituted pyridones having cytokine inhibitory activityMERCK & CO INC·Filed 2000·Granted Jun 11, 2002·14 cites·4 claims
- 2783US7053089B2N-substituted nonaryl-heterocyclic NMDA/NR2B antagonistsMERCK & CO INC·Filed 2002·Granted May 30, 2006·13 cites·40 claims
- 2882US8927569B2Macrocyclic compounds as antiviral agentsHARPER STEVEN·Filed 2008·Granted Jan 6, 2015·8 cites·17 claims
- 2982US6319944B1Aryl amidines, compositions containing such compounds and methods of useMERCK & CO INC·Filed 2000·Granted Nov 20, 2001·21 cites·22 claims
- 3081US9328138B2HCV NS3 protease inhibitorsMERCK SHARP & DOHME·Filed 2012·Granted May 3, 2016·8 cites·17 claims
- 3181US6083949ASubstituted imidazoles having anti-cancer and cytokine inhibitory activityMERCK & CO INC·Filed 1998·Granted Jul 4, 2000·28 cites·15 claims
- 3281US5821241AFibrinogen receptor antagonistsMERCK & CO INC·Filed 1994·Granted Oct 13, 1998·21 cites·16 claims
- 3380US9938276B26,5-bicyclic octahydropyrrolopyridine orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2015·Granted Apr 10, 2018·2 cites·11 claims
- 3480US9573939B2Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseasesMCCOMAS CASEY C·Filed 2012·Granted Feb 21, 2017·6 cites·6 claims
- 3579US6838291B2Radioligand and binding assayMERCK & CO INC·Filed 2001·Granted Jan 4, 2005·8 cites·16 claims
- 3678US7217716B2N-substituted nonaryl-heterocyclic NMDA/NR2B antagonistsMERCK & CO INC·Filed 2002·Granted May 15, 2007·8 cites·9 claims
- 3777US7259157B2N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B AntagonistsMERCK & CO INC·Filed 2002·Granted Aug 21, 2007·12 cites·16 claims
- 3877US6492516B1Compounds having cytokine inhibitory activityMERCK & CO INC·Filed 2000·Granted Dec 10, 2002·9 cites·1 claims
- 3977US6194458B1Benzamide potassium channel inhibitorsMERCK & CO INC·Filed 1999·Granted Feb 27, 2001·43 cites·19 claims
- 4076US6632836B1Carbocyclic potassium channel inhibitorsMERCK & CO INC·Filed 1999·Granted Oct 14, 2003·45 cites·23 claims
- 4175US6303637B1Heterocyclic potassium channel inhibitorsMERCK & CO INC·Filed 1999·Granted Oct 16, 2001·39 cites·11 claims
- 4275US5451578AFibrinogen receptor antagonistsMERCK & CO INC·Filed 1994·Granted Sep 19, 1995·15 cites·19 claims
- 4373US7196095B2(Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and PKG kinase inhibiting compoundsMERCK & CO INC·Filed 2002·Granted Mar 27, 2007·8 cites·25 claims
- 4473US5658901A2,3-dihydro-1-(2,2,2,-trifluoroethyl)-2-oxo-5-phenyl-1H-1,4-benzodiazepinesMERCK & CO INC·Filed 1995·Granted Aug 19, 1997·38 cites·10 claims
- 4571US6767908B2Substituted imidazoles having cytokine inhibitory activityMERCK & CO INC·Filed 2000·Granted Jul 27, 2004·4 cites·3 claims
- 4670US10150751B2Pyrrolidine orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2015·Granted Dec 11, 2018·1 cites·9 claims
- 4770US5426185AAntiarrhythmic benzodiazepinesMERCK & CO INC·Filed 1993·Granted Jun 20, 1995·21 cites·11 claims
- 4869US6207687B1Substituted imidazoles having cytokine inhibitory activityMERCK & CO INC·Filed 1999·Granted Mar 27, 2001·21 cites·4 claims
- 4967US9828368B2Oxazole orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted Nov 28, 2017·1 cites·12 claims
- 5067US9549917B2Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseasesMCCOMAS CASEY C·Filed 2012·Granted Jan 24, 2017·1 cites·14 claims
Showing the top 50 of 96 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Nigel J. Liverton files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →